课题基金 / 基金详情

Optimisation of peptidic non-phosphorylated inhibitors of the Grb7 SH2 domain

Optimisation of peptidic non-phosphorylated inhibitors of the Grb7 SH2 domain
Grb7 SH2 结构域肽类非磷酸化抑制剂的优化
批准号:
DP0987761
负责人:
Prof Jacqueline Wilce
金额:
$29.1万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Discovery Projects
财政年份:
2009
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2009-01-05 至 2011-12-31

项目摘要

项目成果

Prof Jacqueline Wilce的其他基金

相似基金

相关文献

中文摘要
翻译
研究成果将在抑制剂开发领域具有根本性的重要性,因此将在高知名度的国际期刊上发表,并继续为澳大利亚在生物研究方面的杰出国际声誉做出贡献。有机会参与该项目的学生和研究人员将在生物化学、科学严谨性和演讲技巧方面接受最先进技术的使用培训,从而为我国劳动力的质量做出贡献。此外,从这项工作中产生的应用将有助于澳大利亚的知识产权和制药工业的未来发展。
英文摘要
The research outcomes will be of fundamental importance in the field of inhibitor development and as such will result in publications in high-profile international journals and continue to contribute to Australia's outstanding international reputation in biological research. Students and research associates that have the opportunity to work on this project will be trained in the use of state-of-the art technologies in biochemistry, scientific rigour and presentation skills and thus contribute to the quality of our national workforce. Furthermore, applications that arise from this work will contribute to Australia's intellectual property and future developments in the pharmaceutical industry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The RGG/RG motif as an RNA chaperone: advancing CRISPR-Cas RNA technology
  • 批准号:
    DP200102737
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $29.49万
  • 财政年份:
    2020
  • 负责人:
    Prof Jacqueline Wilce
  • 依托单位:
海外基金